Higher prevalence was seen for antiviral-treated patients compared with untreated counterparts. (HealthDay News) — Patients with chronic hepatitis B (CHB) have an increased prevalence of chronic ...

Late-breaking Phase 2 trial data evaluating the safety and efficacy of 25 mg of lorundrostat in participants with hypertension and comorbid CKD ...

As the lights went out in her hometown, 40-year-old Zinaida Kot could not help but think about her next dialysis treatment ...

"The pervasive presence of phthalates results in nearly unavoidable exposure in the general population, with CKD patients likely experiencing even higher levels due to their medical treatment ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

ProKidney Corp. (Nasdaq: PROK) ('ProKidney” or the 'Company'), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that the Company ...

In a new study published in the Journal of Clinical Investigation, they show that a special antibody called ABTAA can help ...

FDA approval based on superiority of Gazyva/Gazyvaro over standard therapy alone, as shown in phase II NOBILITY and phase III REGENCY data1,2Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody t ...

Chronic kidney disease, or CKD, is a serious health problem affecting millions of people around the world. People with this ...

Chronic kidney disease (CKD) is correlated with sudden cardiac death (SCD), according to an October study published in Nature Communications.

As part of the FDA's rolling review of the biologics license application, Vertex expects to submit the first module to the regulator for potential accelerated approval before the end of 2025, and said ...

Lupus continues to carry a heavy burden despite advances in immunosuppressive therapy warranting complementary care ...